CA-VISA-INC.
11.7.2024 22:08:28 CEST | Business Wire | Press release
With the Opening Ceremony in Paris about two weeks away, Visa (NYSE: V), the Worldwide Payment Technology Partner of the Olympic and Paralympic Games, today announced its final roster of 147 Team Visa athletes for Paris 2024. Visa also shares ways to connect fans to the spirit of Paris 2024, both for those in attendance and those who want to participate at home.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240711202801/en/
Team Visa Olympic and Paralympic Games Paris 2024 (Photo: Business Wire)
“As the Worldwide Payment Technology Partner of the Olympic and Paralympic Games, we’re excited to integrate Visa products and platforms that create value for both the athlete and fan experience during Paris 2024,” said Frank Cooper, CMO, Visa. “The Team Visa athletes preparing to compete in the Olympic and Paralympic Games Paris 2024 have consistently taken small steps over many years to reach this goal. We have supported these incredible athletes in their quest and want to help share their journeys with the world.”
Introducing Team Visa for Paris 2024
Founded in 2000, Team Visa has championed nearly 700 athletes over the last quarter century – each selected because of their athletic achievements, community involvement, and alignment with Visa’s core values of equality, access, and inclusion. Team Visa for Paris 2024 includes decorated Olympians and Paralympians like Simone Biles (USA, Gymnastics), Sky Brown (Great Britain, Skateboarding), Noah Lyles (USA, Athletics - Sprint) and Raissa Rocha Machado (Brazil, Para Athletics - Javelin) as well as first-timers like Shigeyuki Nakarai (Japan, Breaking) and Goodness Nwachukwu (Nigeria, Para Athletics - Discus). Team Visa also welcomes refugee athlete Dina Pouryounes (Taekwondo), forced to flee her homeland in the North of Iran to find refuge in The Netherlands.
“Visa has always been committed to empowering athletes on and off the track and it is great to see that in action,” said Noah Lyles. “I’m looking forward to getting in the blocks in Paris and putting it all out there. I have so much gratitude for my support system who has been with me every step of the way, including Team Visa.”
Team Visa by-the-numbers
- 147 athletes representing 67 countries, 40 sports, including the new Breaking competition, making this Visa’s largest, most diverse roster yet, and with 46 Paralympic athletes and hopefuls, our largest Paralympic roster to date
- 80 female and 67 male – underscoring Visa’s commitment to inclusion in sport
- Record breakers and world #1s like Iga Świątek (Poland, Tennis), PV Sindhu (India, Badminton), and Simone Biles (USA, Gymnastics)
- Newcomers and veterans alike, such as first-timers Qingyi Liu (China, Breaking) and Alexia Putellas (Spain, Football) and returners Kanoa Igarashi (Japan, Surfing) and Adam Peaty (Great Britain, Swimming)
Engaging fans in Paris and around the world
In the spirit of the theme “Pas Sans Vous,” or “Not Without You,” Visa is taking action to ensure everyone, everywhere can participate in Paris 2024:
- Visa Go, a new mobile application for Visa cardholders visiting the Olympic and Paralympic Games Paris 2024, offers access to unique experiences and exclusive content, spotlights Team Visa athletes and shares their progress during Paris 2024. The app will also offer a curated selection of discounts and offers from official partners and local shops and restaurants. Fans can purchase a virtual Visa prepaid card through Visa Go, if needed.
- Blending sports with culture, Visa has commissioned six global artists to create works of art to appear on billboards throughout Paris and other nearby host cities celebrating Paris 2024 and highlighting local commerce. In a tribute to Paris, the global capital for street art, pieces will appear on billboards in train stations, airports, the metro, and elsewhere around the cities to help support and promote local small businesses, who contribute to the city’s vitality. Participating artists include leading street artist from Seine-Saint-Denis Marko 93 (France); influential street artist and activist Swoon (USA); pioneering graffiti artist JonOne (USA); native Parisian artist Olivia De Bona (France); prolific colorblind street artist Alex Senna (Brazil); and multidisciplinary artist Vexta (Australia).
- A custom payment services solution that Visa has implemented for Paris 2024 will bring seamless contactless payment acceptance to 3,500 points of sale across 32 Olympic venues and 16 Paralympic venues.
- In recognition of Visa’s long-standing partnership with the Olympic and Paralympic Games, Paris 2024 proudly accepts only Visa for card and mobile payments, along with cash, at Olympic and Paralympic venues as well as the flagship Paris 2024 Megastore on Paris’ iconic Champs-Élysées and other official merchandise shops around France. Visa is also the Official Way to Pay for official merchandise online at the Olympic Shop.
- Fans can join the fun on Roblox at Olympic World presented by Visa, a new immersive experience that features a unique collection of sports-themed activities, quests, and fun facts.
In the Paris metro area, “Pas Sans Vous” will come to life through Visa’s commitment to giving back to local youth and small business. Visa has partnered with youth sports program Sport Dans La Ville, providing hundreds of tickets to Paris 2024 for program participants, funding new sports centers and a girls mentorship program, as well as a development program for young journalists with Le Monde, one of France’s top news platforms. Additionally, Visa invited small businesses across France to participate in the “Les Paiements Gagnants,” or “Winning Payments” national promotion, in which more than 25,000 small businesses opted in to offer Visa cardholders a chance to win Paris 2024 tickets, helping small businesses to benefit more from the commercial opportunities that the Olympic and Paralympic Games bring.
Learn more about Visa’s commitment to the Olympic and Paralympic Games here.
About Visa
Visa (NYSE: V) is a world leader in digital payments, facilitating transactions between consumers, merchants, financial institutions and government entities across more than 200 countries and territories. Our mission is to connect the world through the most innovative, convenient, reliable and secure payments network, enabling individuals, businesses and economies to thrive. We believe that economies that include everyone everywhere, uplift everyone everywhere and see access as foundational to the future of money movement. Learn more at Visa.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240711202801/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Altasciences Supports 4B Healthcare in Advancing Steroid Nasal Irrigation Rinse to Clinical Trials24.9.2026 14:40:00 CEST | Press release
Altasciences is proud to announce that recent formulation work supporting 4B Healthcare Inc. (“4B”) has helped advance its RhineX nasal irrigation rinse therapy into clinical investigation. Following several months of formulation development, R&D manufacturing, stability testing, and quality assurance support at Altasciences’ CDMO facility in Harleysville, PA, the Tennessee-based pharmaceutical company has received FDA clearance to proceed with clinical testing of RhineX under its IND. First subject dosing is planned for October 2026, approximately seven months after formulation development began. "The concept for RhineX grew out of a problem I have seen in my own ENT practice for years—the need for a better treatment option for allergic rhinitis when conventional medical therapy is not enough,” said Brannon Mangus, MD, Co-Founder and CEO of 4B. “We founded 4B Healthcare to take that physician insight and turn it into a pharmaceutical product that could meaningfully change how these pa
ParaScript Acquired by Stakk to Create a Global Digital Trust Platform Focused on Combating Fraud24.9.2026 14:30:00 CEST | Press release
ParaScript’s AI-powered document intelligence technology integrates with Stakk’s SaaS platform to provide regulated organizations with a stronger defense against AI-driven digital identity fraud.Complementary technologies establish digital trust by continuously assessing identity, documents, behavior and context, making explainable decisions in milliseconds.Combined businesses serve more than 300 enterprise customers and processes more than 110 billion digital interactions annually across the U.S., Europe, the Middle East and Australia. ParaScript, an Al-powered document processing company, today announced that Stakk Limited (ASX: SKK) (“Stakk”), a company publicly traded on the Australian Stock Exchange (ASX), has successfully completed its US$63 million (A$88.7 million) acquisition of ParaScript, LLC and ParaScript Management, Inc. (“ParaScript”), creating a scaled and profitable AI-native digital trust platform. Stakk acquired ParaScript for its industry-leading AI-powered document
SLB Awarded Four Multi-Year Integrated Well Construction Contracts by Aramco24.9.2026 14:04:00 CEST | Press release
Awards expand deployment of SLB's integrated well construction model across Saudi Arabia’s oil and gas reservoirs Global energy technology company SLB (NYSE: SLB) today announced it has been awarded four integrated well construction contracts by Aramco to support oil and gas development across the Kingdom of Saudi Arabia. Under the contracts, SLB will manage end-to-end well construction services, delivering more than 450 wells in the three-year term, with an optional extension of up to two years. "Delivering hundreds of wells across a multi-year program and in multiple operating environments requires an integrated model that connects planning, execution, and digital workflows to set new industry performance benchmarks,” said Steve Gassen, executive vice president of Geographies for SLB. “Awarding SLB these advanced well construction programs at scale reflects Aramco’s confidence in our integrated model and capabilities." SLB's integrated well construction model brings together every as
Sahajanand Medical Technologies Receives EU MDR Certification for Supraflex Cruz and Product Family, Reinforcing Global Compliance and Patient Safety24.9.2026 14:03:00 CEST | Press release
Sahajanand Medical Technologies Limited (SMT), a leading global manufacturer of cardiovascular medical devices, today announced that it has received certification under the European Union Medical Device Regulation (EU MDR 2017/745) for Supraflex Cruz and its product family. SMT is a leading player in India’s drug-eluting stent market and ranks among the top five companies in key European markets, including Germany, Spain and Poland. The certification follows the conformity assessment process established under EU MDR 2017/745 including assessment of SMT’s technical documentation, clinical evaluation and quality management system. Together with SMT’s existing ISO 13485 quality management system and MDSAP certifications, the EU MDR certification confirms that Supraflex Cruz has successfully undergone assessment against the EU MDR’s stringent requirements for safety, performance and clinical evidence. Supraflex Cruz is a sirolimus-eluting coronary stent system designed to improve luminal d
Acadia Pharmaceuticals Announces Phase 3 Enabling Topline Results from Phase 2 RADIANT Study of Remlifanserin for the Treatment of Alzheimer’s Disease Psychosis (ADP)24.9.2026 13:00:00 CEST | Press release
-- Meaningful and consistent efficacy trends across endpoints support continuing with Phase 3 development of 60 mg once daily remlifanserin in ADP, with demonstrated evidence of dose effect-- Narrowly missed primary endpoint of SAPS H+D (p=0.0603) with significance (nominal) on key secondary endpoint of CGI-S-ADP (p=0.0077)-- Favorable safety and tolerability profile across both doses-- Detailed results to be presented at upcoming Clinical Trials on Alzheimer's Disease (CTAD) conference in November-- Conference call and webcast to be held today at 8:00 a.m. Eastern Time Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced Phase 3 enabling topline results from the Phase 2 portion of the ongoing RADIANT clinical trial program evaluating remlifanserin for the treatment of hallucinations and delusions associated with Alzheimer’s disease psychosis (ADP). For the primary endpoint of change from baseline in the Scale for the Assessment of Positive Symptoms-Hallucinations and Delusions s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom